These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

458 related articles for article (PubMed ID: 29771149)

  • 21. Folic acid Targeted Polymeric Micelles Based on Tocopherol Succinate- Pulluan as an Effective Carrier for Epirubicin: Preparation, Characterization and In-vitro Cytotoxicity Assessment.
    Hassanzadeh F; Mehdifar M; Varshosaz J; Khodarahmi GA; Rostami M
    Curr Drug Deliv; 2018 Feb; 15(2):235-246. PubMed ID: 28571542
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dual functional matrix metalloproteinase-responsive curcumin-loaded nanoparticles for tumor-targeted treatment.
    Guo F; Fu Q; Jin C; Ji X; Yan Q; Yang Q; Wu D; Gao Y; Hong W; Li A; Yang G
    Drug Deliv; 2019 Dec; 26(1):1027-1038. PubMed ID: 31691601
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dual-functional liposomes based on pH-responsive cell-penetrating peptide and hyaluronic acid for tumor-targeted anticancer drug delivery.
    Jiang T; Zhang Z; Zhang Y; Lv H; Zhou J; Li C; Hou L; Zhang Q
    Biomaterials; 2012 Dec; 33(36):9246-58. PubMed ID: 23031530
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatoma-targeting and pH-sensitive nanocarriers based on a novel D-galactopyranose copolymer for efficient drug delivery.
    Ding Y; Han J; Tian B; Han J; Zhang J; Zheng H; Han Y; Pei M
    Int J Pharm; 2014 Dec; 477(1-2):187-96. PubMed ID: 25455771
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preparation, in vitro and in vivo evaluation of mPEG-PLGA nanoparticles co-loaded with syringopicroside and hydroxytyrosol.
    Guan Q; Sun S; Li X; Lv S; Xu T; Sun J; Feng W; Zhang L; Li Y
    J Mater Sci Mater Med; 2016 Feb; 27(2):24. PubMed ID: 26704541
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PEGylated self-assembled enzyme-responsive nanoparticles for effective targeted therapy against lung tumors.
    Guo F; Wu J; Wu W; Huang D; Yan Q; Yang Q; Gao Y; Yang G
    J Nanobiotechnology; 2018 Jul; 16(1):57. PubMed ID: 30012166
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chemotherapeutic drug-photothermal agent co-self-assembling nanoparticles for near-infrared fluorescence and photoacoustic dual-modal imaging-guided chemo-photothermal synergistic therapy.
    Li Y; Liu G; Ma J; Lin J; Lin H; Su G; Chen D; Ye S; Chen X; Zhu X; Hou Z
    J Control Release; 2017 Jul; 258():95-107. PubMed ID: 28501673
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Smart nanocarrier based on PEGylated hyaluronic acid for cancer therapy.
    Choi KY; Yoon HY; Kim JH; Bae SM; Park RW; Kang YM; Kim IS; Kwon IC; Choi K; Jeong SY; Kim K; Park JH
    ACS Nano; 2011 Nov; 5(11):8591-9. PubMed ID: 21967065
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improved oral efficacy of epirubicin through polymeric nanoparticles: pharmacodynamic and toxicological investigations.
    Tariq M; Alam MA; Singh AT; Panda AK; Talegaonkar S
    Drug Deliv; 2016 Oct; 23(8):2990-2997. PubMed ID: 26800371
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preparation of folate-modified pullulan acetate nanoparticles for tumor-targeted drug delivery.
    Zhang HZ; Li XM; Gao FP; Liu LR; Zhou ZM; Zhang QQ
    Drug Deliv; 2010 Jan; 17(1):48-57. PubMed ID: 22747075
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Improved anticancer efficacy of epirubicin by magnetic mesoporous silica nanoparticles: in vitro and in vivo studies.
    Ansari L; Jaafari MR; Bastami TR; Malaekeh-Nikouei B
    Artif Cells Nanomed Biotechnol; 2018; 46(sup2):594-606. PubMed ID: 29688064
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti-EGFR-iRGD recombinant protein modified biomimetic nanoparticles loaded with gambogic acid to enhance targeting and antitumor ability in colorectal cancer treatment.
    Zhang Z; Qian H; Huang J; Sha H; Zhang H; Yu L; Liu B; Hua D; Qian X
    Int J Nanomedicine; 2018; 13():4961-4975. PubMed ID: 30214200
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Optimization of epirubicin nanoparticles using experimental design for enhanced intravesical drug delivery.
    Chang LC; Wu SC; Tsai JW; Yu TJ; Tsai TR
    Int J Pharm; 2009 Jul; 376(1-2):195-203. PubMed ID: 19439169
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intratumoral injection of gels containing losartan microspheres and (PLG-g-mPEG)-cisplatin nanoparticles improves drug penetration, retention and anti-tumor activity.
    Yu M; Zhang C; Tang Z; Tang X; Xu H
    Cancer Lett; 2019 Feb; 442():396-408. PubMed ID: 30439541
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plaque-hyaluronidase-responsive high-density-lipoprotein-mimetic nanoparticles for multistage intimal-macrophage-targeted drug delivery and enhanced anti-atherosclerotic therapy.
    Zhang M; He J; Jiang C; Zhang W; Yang Y; Wang Z; Liu J
    Int J Nanomedicine; 2017; 12():533-558. PubMed ID: 28144137
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epirubicin-loaded marine carrageenan oligosaccharide capped gold nanoparticle system for pH-triggered anticancer drug release.
    Chen X; Han W; Zhao X; Tang W; Wang F
    Sci Rep; 2019 May; 9(1):6754. PubMed ID: 31043709
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preparation, characterization and evaluation of antibacterial properties of epirubicin loaded PHB and PHBV nanoparticles.
    Perveen K; Masood F; Hameed A
    Int J Biol Macromol; 2020 Feb; 144():259-266. PubMed ID: 31821825
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Facile fabrication of multi-pocket nanoparticles with stepwise size transition for promoting deep penetration and tumor targeting.
    Hou X; Zhong D; Li Y; Mao H; Yang J; Zhang H; Luo K; Gong Q; Gu Z
    J Nanobiotechnology; 2021 Apr; 19(1):111. PubMed ID: 33874945
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Polysialic acid-modifying liposomes for efficient delivery of epirubicin, in-vitro characterization and in-vivo evaluation.
    Zhang T; Zhou S; Hu L; Peng B; Liu Y; Luo X; Song Y; Liu X; Deng Y
    Int J Pharm; 2016 Dec; 515(1-2):449-459. PubMed ID: 27789365
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Integrin-targeted zwitterionic polymeric nanoparticles with acid-induced disassembly property for enhanced drug accumulation and release in tumor.
    Huang P; Song H; Wang W; Sun Y; Zhou J; Wang X; Liu J; Liu J; Kong D; Dong A
    Biomacromolecules; 2014 Aug; 15(8):3128-38. PubMed ID: 25054812
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.